Carbapenem-Resistant Enterobacteriaceae Infections: Taiwan Aspects [PDF]
Carbapenem-resistant Enterobacteriaceae (CRE), a major resistance concern emerging during the last decade because of significantly compromising the efficacy of carbapenem agents, has currently become an important focus of infection control.
Shio-Shin Jean +8 more
doaj +6 more sources
Therapeutic options for carbapenem-resistant Enterobacteriaceae infections [PDF]
In recent years, carbapenem resistance among Enterobacteriaceae has dramatically increased and represents an important threat to global health. The optimal therapeutic management of carbapenem-resistant Enterobacteriaceae (CRE) infections has not been established, because to date, no clinical trials have been performed with this objective.
Enrico Trecarichi, Mario Tumbarello
exaly +5 more sources
Deaths Attributable to Carbapenem-Resistant Enterobacteriaceae Infections [PDF]
We evaluated the number of deaths attributable to carbapenem-resistant Enterobacteriaceae by using studies from around the world published before April 9, 2012.
Matthew E. Falagas +3 more
doaj +4 more sources
Paediatric Enterobacteriaceae infections in hospitalised children in Durban, KwaZulu-Natal
Background: Community-acquired Gram-negative Enterobacteriaceae infections in malnourished and HIV-infected hospitalised children are not well documented and are of concern because of increasing antibiotic resistance and limited available treatment ...
Harshna Krishinchand +3 more
doaj +2 more sources
Carbapenem and colistin resistance in children with Enterobacteriaceae infections [PDF]
Background. Carbapenem-resistant Enterobacteriaceae (CRE) are an emerging global public health threat. As a reserve agent, colistin has been the drug of choice for the treatment of infections caused by CRE.
Zeliha Haytoğlu +5 more
doaj +3 more sources
Treatment of Carbapenem-Resistant Enterobacteriaceae Infections in Children. [PDF]
AbstractInfections due to carbapenem-resistant Enterobacteriaceae (CRE) are increasingly prevalent in children and are associated with poor clinical outcomes. Optimal treatment strategies for CRE infections continue to evolve. A lack of pediatric-specific comparative effectiveness data, uncertain pediatric dosing regimens for several agents, and a ...
Chiotos K, Hayes M, Gerber JS, Tamma PD.
europepmc +4 more sources
Carbapenem-Resistant Enterobacteriaceae Infections in Children. [PDF]
Carbapenem-resistant Enterobacteriaceae (CRE) are an emerging global public health threat. Infections due to CRE are associated with significant morbidity and mortality. Few therapeutic options are available for treatment of these infections, and optimal antibiotic treatment regimens are unclear.
Chiotos K, Han JH, Tamma PD.
europepmc +4 more sources
Plazomicin for Infections Caused by Carbapenem-Resistant Enterobacteriaceae
Plazomicin for Severe Resistant Infection This report compared plazomicin with colistin for the treatment of severe (bloodstream or pneumonia) infection with carbapenem-resistant Enterobacteriaceae...
George Daikos +2 more
exaly +4 more sources
Treatment Options for Carbapenem-Resistant Enterobacteriaceae Infections. [PDF]
Abstract This article provides a comprehensive review of currently available treatment options for infections due to carbapenem-resistant Enterobacteriaceae (CRE). Antimicrobial resistance in Gram-negative bacteria is an emerging and serious global public health threat.
Morrill HJ +3 more
europepmc +5 more sources
Carbapenem Resistant Enterobacteriaceae infections in Houston, Texas: An outline [PDF]
ObjectiveTo examine demographic as well as clinical characteristics of theCarbapenam Resistant Enteriobacteriacae (CRE) Organisms cases inHouston, Texas, 2015-2016IntroductionAccording to CDC, CRE is used to describe bacteria that are non-susceptible to one or more carbapenems; doripenem, meropenemor imipenem and resistant to third generation ...
Rehman, Hafeez +3 more
europepmc +3 more sources

